📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Ketamine treatment for depression: opportunities for clinical innovation and ethical foresight. (2017)

First Author: Singh I

Attributed to: Reducing relapse in alcohol dependence with the NMDA receptor antagonist, ketamine funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2215-0366(17)30102-5

PubMed Identifier: 28395988

Publication URI: http://europepmc.org/abstract/MED/28395988

Type: Journal Article/Review

Volume: 4

Parent Publication: The lancet. Psychiatry

Issue: 5

ISSN: 2215-0366